• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管危险因素对阿尔茨海默病进展的累积效应。

Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease.

机构信息

Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan.

Faculty of Medicine, National Yang-Ming University Schools of Medicine, Taipei, Taiwan.

出版信息

J Am Geriatr Soc. 2020 Jan;68(1):129-136. doi: 10.1111/jgs.16181. Epub 2019 Oct 6.

DOI:10.1111/jgs.16181
PMID:31587263
Abstract

OBJECTIVES

To investigate the summative effects of vascular risk factors (VRFs) on the progression of Alzheimer disease (AD).

DESIGN

Longitudinal follow-up cohort study.

SETTING

AD patients from two teaching hospitals in Taiwan with 3-year follow-ups.

PARTICIPANTS

A total of 330 AD patients with a mean age of 80.7 years, a mean Mini-Mental State Examination (MMSE) score 18.7, and a mean Clinical Dementia Rating Sum of Boxes (CDRSB) score of 6.9.

MEASUREMENTS

All patients completed a clinically functional assessment and a neuropsychological test battery at baseline and yearly follow-ups. The VRF burden was combined into a summative VRF index at baseline (ie, having one, two, or more VRFs); VRFs included coronary heart disease, cardiac arrhythmia, hypertension, cerebrovascular disease, diabetes mellitus, obesity, smoking, and physical inactivity. The generalized estimating equation (GEE) method was used to analyze the correlations between the VRFs and longitudinal MMSE and CDRSB changes.

RESULTS

The results of the GEE adjusted for age, years of education, sex, disease duration, baseline MMSE score, time, apolipoprotein E (APOE) ε4 carrier status, use of medications (acetylcholinesterase inhibitors or N-methyl-D-aspartate receptor antagonists), and hospitalization rates and showed that patients with more than three VRFs had more rapid cognitive decline than patients without VRFs (MMSE, P = .02; CDRSB, P = .001) as well as patients with three or fewer VRFs (MMSE, P = .009; CDRSB, P = .02). Subsequent analyses of APOE ε4 carriers with more than three VRFs also showed their more rapid cognitive decline compared with patients without VRFs (MMSE, P = .02; CDRSB, P = .001) and patients with three or fewer VRFs (MMSE, P = .009; CDRSB, P = .02), but no significant difference was found in APOE ε4 noncarriers.

CONCLUSION

Multiple VRFs have summative effects on the progression of AD, especially in APOE ε4 carriers. J Am Geriatr Soc 68:129-136, 2019.

摘要

目的

研究血管危险因素 (VRF) 对阿尔茨海默病 (AD) 进展的综合影响。

设计

纵向随访队列研究。

地点

台湾两所教学医院的 AD 患者,随访 3 年。

参与者

共纳入 330 名 AD 患者,平均年龄 80.7 岁,平均简易精神状态检查 (MMSE) 评分 18.7,平均临床痴呆评定量表总评分 (CDRSB) 6.9。

评估

所有患者均在基线及每年随访时进行临床功能评估和神经心理学测试。VRF 负担在基线时组合成一个综合 VRF 指数(即存在一个、两个或更多 VRF);VRF 包括冠心病、心律失常、高血压、脑血管疾病、糖尿病、肥胖、吸烟和缺乏身体活动。使用广义估计方程 (GEE) 方法分析 VRF 与纵向 MMSE 和 CDRSB 变化之间的相关性。

结果

在调整年龄、受教育年限、性别、疾病持续时间、基线 MMSE 评分、时间、载脂蛋白 E (APOE) ε4 携带状态、药物使用(乙酰胆碱酯酶抑制剂或 N-甲基-D-天冬氨酸受体拮抗剂)和住院率后,GEE 的结果显示,患有超过三个 VRF 的患者认知衰退速度比没有 VRF 的患者更快(MMSE,P=0.02;CDRSB,P=0.001),也比患有三个或更少 VRF 的患者更快(MMSE,P=0.009;CDRSB,P=0.02)。对患有超过三个 VRF 且携带 APOE ε4 的患者进行的后续分析也显示,与没有 VRF 的患者(MMSE,P=0.02;CDRSB,P=0.001)和患有三个或更少 VRF 的患者(MMSE,P=0.009;CDRSB,P=0.02)相比,他们的认知衰退速度更快,但在非 APOE ε4 携带者中未发现显著差异。

结论

多种 VRF 对 AD 的进展具有综合影响,尤其是在 APOE ε4 携带者中。

美国老年医学会杂志 68:129-136,2019 年。

相似文献

1
Summative Effects of Vascular Risk Factors on the Progression of Alzheimer Disease.血管危险因素对阿尔茨海默病进展的累积效应。
J Am Geriatr Soc. 2020 Jan;68(1):129-136. doi: 10.1111/jgs.16181. Epub 2019 Oct 6.
2
Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.载脂蛋白E基因分型对轻度认知障碍门诊患者阿尔茨海默病的预测效用
Arch Neurol. 2005 Jun;62(6):975-80. doi: 10.1001/archneur.62.6.975.
3
Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.载脂蛋白 E ɛ4 阴性早发性阿尔茨海默病认知衰退最快。
Psychol Med. 2009 Nov;39(11):1907-11. doi: 10.1017/S0033291709005492. Epub 2009 Apr 1.
4
APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.载脂蛋白E与临床前阿尔茨海默病及非痴呆性衰老中的认知衰退
Neurology. 2004 Sep 14;63(5):816-21. doi: 10.1212/01.wnl.0000137041.86153.42.
5
Association of Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease.基因型与阿尔茨海默病认知衰退率异质性的关联。
Neurology. 2021 May 11;96(19):e2414-e2428. doi: 10.1212/WNL.0000000000011883. Epub 2021 Mar 26.
6
Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.台湾地区接受药物治疗的阿尔茨海默病患者的纵向神经心理学转归
Curr Alzheimer Res. 2018 Mar 14;15(5):474-481. doi: 10.2174/1567205014666171010112518.
7
Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.载脂蛋白E ε4等位基因与阿尔茨海默病的认知或功能衰退无关:回顾性和前瞻性分析。
Dement Geriatr Cogn Disord. 2006;22(1):73-82. doi: 10.1159/000093316. Epub 2006 May 12.
8
Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.载脂蛋白Eɛ4携带者状态对阿尔茨海默病患者乙酰胆碱酯酶抑制剂认知反应的影响:一项系统评价和荟萃分析
Dement Geriatr Cogn Disord. 2018;45(5-6):335-352. doi: 10.1159/000490175. Epub 2018 Jul 24.
9
Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.抗胆碱能药物与载脂蛋白Eε4等位基因及老年心血管疾病患者认知功能较差之间的关联:一项横断面研究。
J Am Geriatr Soc. 2009 Mar;57(3):427-31. doi: 10.1111/j.1532-5415.2008.02129.x.
10
Cognitive impairment in Alzheimer's disease is modified by APOE genotype.阿尔茨海默病中的认知障碍会因载脂蛋白E(APOE)基因型而改变。
Dement Geriatr Cogn Disord. 2007;24(2):98-103. doi: 10.1159/000104467. Epub 2007 Jun 26.

引用本文的文献

1
Cardiovascular disease risk models and dementia or cognitive decline: a systematic review.心血管疾病风险模型与痴呆或认知衰退:一项系统综述
Front Aging Neurosci. 2023 Oct 12;15:1257367. doi: 10.3389/fnagi.2023.1257367. eCollection 2023.
2
Exploring the relationship between patient-relevant outcomes and Alzheimer's disease progression assessed using the clinical dementia rating scale: a systematic literature review.探索使用临床痴呆评定量表评估的与患者相关的结局与阿尔茨海默病进展之间的关系:一项系统文献综述。
Front Neurol. 2023 Aug 17;14:1208802. doi: 10.3389/fneur.2023.1208802. eCollection 2023.
3
Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein ɛ4 Carriers versus Apolipoprotein ɛ3 Homozygotes.
载脂蛋白 E4 携带者与载脂蛋白 E3 纯合子个体的访间血压变异性与认知衰退。
J Alzheimers Dis. 2023;93(2):533-543. doi: 10.3233/JAD-221103.
4
Vitamin D and Its Analogues: From Differences in Molecular Mechanisms to Potential Benefits of Adapted Use in the Treatment of Alzheimer's Disease.维生素 D 及其类似物:从分子机制的差异到在阿尔茨海默病治疗中适应性使用的潜在益处。
Nutrients. 2023 Mar 30;15(7):1684. doi: 10.3390/nu15071684.
5
Dl-3-n-butylphthalide promotes synaptic plasticity by activating the Akt/ERK signaling pathway and reduces the blood-brain barrier leakage by inhibiting the HIF-1α/MMP signaling pathway in vascular dementia model mice.二氢-3-正丁基苯酞通过激活 Akt/ERK 信号通路促进突触可塑性,并通过抑制血管性痴呆模型小鼠中的 HIF-1α/MMP 信号通路降低血脑屏障通透性。
CNS Neurosci Ther. 2023 May;29(5):1392-1404. doi: 10.1111/cns.14112. Epub 2023 Feb 8.
6
Early-stage differentiation between Alzheimer's disease and frontotemporal lobe degeneration: Clinical, neuropsychology, and neuroimaging features.阿尔茨海默病与额颞叶痴呆的早期鉴别:临床、神经心理学及神经影像学特征
Front Aging Neurosci. 2022 Oct 31;14:981451. doi: 10.3389/fnagi.2022.981451. eCollection 2022.
7
Mental and physical health pathways linking insomnia symptoms to cognitive performance 14 years later.14 年后,将失眠症状与认知表现联系起来的心理和身体健康途径。
Sleep. 2023 Mar 9;46(3). doi: 10.1093/sleep/zsac262.
8
Transcranial magnetic stimulation treatment in Alzheimer's disease: a meta-analysis of its efficacy as a function of protocol characteristics and degree of personalization.经颅磁刺激治疗阿尔茨海默病:根据方案特点和个体化程度对其疗效的荟萃分析。
J Neurol. 2022 Oct;269(10):5283-5301. doi: 10.1007/s00415-022-11236-2. Epub 2022 Jul 4.
9
Frequency of missed or delayed diagnosis in dementia is associated with neighborhood socioeconomic status.痴呆症漏诊或延迟诊断的频率与社区社会经济地位相关。
Alzheimers Dement (N Y). 2022 Mar 24;8(1):e12271. doi: 10.1002/trc2.12271. eCollection 2022.
10
Absence of an Association between Macular Degeneration and Young-Onset Dementia.黄斑变性与早发性痴呆之间不存在关联。
J Pers Med. 2022 Feb 16;12(2):291. doi: 10.3390/jpm12020291.